Supernus Offers Business Update: Reaffirms Does Not Need Added Capital, Will 'Explore a Broad Range of Strategic Opportunities'
September 22, 2014 at 16:16 PM EDT
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) is providing the following business update in light of recent investor filings with the ...